18 results about "Laxative" patented technology

The invention relates to the technical field of medical health and artificial intelligence, and discloses an AI reminding method for a gastroenterology department enteroscope patient to take a laxative, comprising the following steps: S1, guiding the patient to enter an AI interaction interface through a two-dimensional code or an applet entry; s2, generating a personalized medication scheme according to the basic information and the real-time data input by the patient; s3, ensuring that the patient completes an intestinal tract preparation process through a staged guidance and real-time reminding function; s4, performing abnormal reaction identification according to real-time feedback data input by the patient, and adjusting subsequent operation suggestions; and S5, screening potential drug interaction through the integrated drug database, and providing a safe drug use prompt. Personalized data such as age, weight, basic diseases, daily medication and daily work and rest of a patient are collected through the personal information input module, the medication scheme generation module calls a preset algorithm to calculate the optimal medication dosage, medication time nodes are determined, and diet suggestions are generated.

The present invention can provide: a colon purgation tablet having a gel-forming coating layer containing an alginate as a main component, the gel-forming coating layer being introduced into an uncoated tablet containing an osmotic substance, the present invention relates to an uncoated tablet, and more particularly, to an uncoated tablet, such that the osmotic substance contained in the uncoated tablet disintegrates rapidly while preventing damage to gastric mucosa due to a physical collision between the tablet and the gastric mucosa, and thus provides an excellent intestinal cleansing effect. The colon purgation tablet according to the present invention can exhibit an excellent intestinal cleansing effect even at a small dose, and can further improve drug compliance by selectively miniaturizing the tablet or introducing an adhesive to improve a coating layer.

An effervescent laxative composition comprising an acid component, an alkaline component, and a polyethylene glycol is disclosed.

The present invention relates to a colon cleansing composition with improved ease of administration. The composition minimizes side effects caused by excessive ingredient content in conventional colonic laxatives while providing equivalent or superior intestinal cleansing efficacy, thereby remarkably improving patient compliance and ingestion convenience. In addition, as an uncoated tablet requiring no separate coating processes, a preparation that maintains the quality of tablets such as rapid disintegration and does not have a bitter taste can be provided. The present invention provides a pharmaceutical formulation comprising the colon cleansing composition with improved ease of administration and a method for colon cleansing using the formulation, thereby realizing a patient-centered colon cleansing process and ultimately greatly contributing to the improvement of colonoscopy quality.

[Problem] To provide a method or program for obtaining a virtual large intestine cleansing image that can remove residual matter from large intestine imaging data captured without the use of laxatives. [Solution] The method includes: an image input step, in which a captured image representing a part of a patient's large intestine is input; and a virtual large intestine cleansing step, in which a virtual large intestine cleansing image representing a part of the patient's large intestine with residual matter removed from the captured image is obtained. The invention also provides a program for causing a computer to execute the above method for obtaining virtual large intestine cleansing images.

The application provides an intestinal preparation quality real-time evaluation and whole-process management system based on artificial intelligence, which comprises the following functions: patient end provides intestinal preparation start time setting, laxative type selection, examination process and matters needing attention query and online consultation function; medical staff end provides patient management, progress and cleanliness score monitoring, early warning processing, data export and message interaction function, wherein the intelligent data acquisition module acquires multi-dimensional data; the artificial intelligence dynamic scoring module analyzes the data based on a deep learning model, generates a cleanliness pre-score and determines a quality grade; the active early warning and intervention module analyzes the data in real time, issues an early warning and provides intervention suggestions; the medical examination result closed-loop verification module receives the doctor's score after colonoscopy, compares and analyzes the pre-score, and optimizes the evaluation model. The application realizes the standardized guidance, active risk early warning and closed-loop optimization management of the intestinal preparation process, effectively improves the preparation quality, guarantees the safety of patients and optimizes the clinical decision-making.

An effervescent laxative composition comprising an acid component, an alkaline component, and a polyethylene glycol is disclosed.

The invention relates to a painless gastrointestinal endoscopy doctor-patient interaction system, which comprises an interaction system, a medical care client and a user client, and is characterized in that the interaction system is in wireless data connection with the medical care client, and the interaction system is in wireless data connection with the user client. The steps of reservation, diet preparation, laxative preparation and the like can be automatically and intelligently completed, manual intervention is reduced, the medical efficiency is improved, through an automatic and intelligent mode, the labor cost of nurses and the like can be reduced, the operation cost of hospitals is reduced, and the system can automatically and intelligently complete the steps of reservation, diet preparation, laxative preparation and the like according to personal information of patients and suggestions of doctors. According to the painless gastrointestinal endoscopy doctor-patient interaction system, accurate diet guidance, laxative preparation guidance and the like are provided, errors possibly caused by manual guidance are avoided, the examination accuracy is improved, a patient can more conveniently know own examination conditions through the painless gastrointestinal endoscopy doctor-patient interaction system, misunderstanding and dissatisfaction of a doctor are reduced, and the doctor-patient relationship is improved.

The invention belongs to the technical field of biological medicine, and particularly discloses a preparation method and application of laxative rhizoma anemarrhenae homogeneous polysaccharide, the preparation method comprises the following steps: taking rhizoma anemarrhenae total polysaccharide as an initial raw material, performing primary separation on the supernate of the solution through an anion-cation exchange resin column formed by connecting FPA90Cl and IR84 in series, and performing secondary separation on the supernate to obtain the laxative rhizoma anemarrhenae homogeneous polysaccharide. Eluting with distilled water to obtain target crude polysaccharide; further performing gradient elution on supernate of the crude polysaccharide solution through a DEAE Cellulose 52 ion exchange chromatographic column, collecting a main elution peak during elution of 0.6 mol / L NaCl, and performing concentration, distilled water dialysis and freeze drying to obtain high-purity target polysaccharide. According to the invention, the influence of the rhizoma anemarrhenae homogeneous polysaccharide solutions with different concentrations on cell proliferation is evaluated, and the dose-dependent effect is proved; the obvious influence of the polysaccharide on the AQP3 and AQP8 protein levels is proved. The prepared homogeneous polysaccharide can improve the intestinal barrier function, provides a new strategy for treating diarrhea, constipation or colon diseases, and has important clinical value.

The application provides a composition with improved gastrointestinal function and a preparation method thereof, and belongs to the technical field of compositions.The composition comprises the following components in percentage by weight: fructo-oligosaccharides 25-45%, anhydrous magnesium citrate 20-30%, mannitol 10-20%, fruit powder 10-15%, guar gum 5-10%, konjac gum 1-5%, colloidal silicon dioxide 0.5-1% and steviol glycoside 0.1-0.5%; the application adopts a fermentation process on fructo-oligosaccharides, guar gum and konjac gum to obtain fermentation metabolites, the fermentation metabolites have a chemical stimulation peristalsis and combine the osmotic laxative of magnesium salt and the microecological regulation effect of prebiotics, and the pain points of traditional fiber preparations, such as sticky taste and slow effect, are solved.

The utility model discloses a bowel preparation U type colorimetric recording ruler relates to bowel preparation degree detection technical field, including horizontal vernier and U type color liquid mark. The utility model discloses in the last bowel cleaning agent oral time is recorded conveniently, and the reference is provided for anaesthetic risk assessment, the stool frequency after bowel cleaning agent oral is recorded conveniently, and the degree of bowel cleaning is judged, and the medical record is provided with the convenience simultaneously, the stool situation is compared conveniently, and the reference is provided for medical staff judgement bowel preparation situation, and the patient is convenient, easy to use, and the patient is convenient to understand, and the medical work efficiency is promoted, the product can be used to bowel operation, and the bowel cleaning of the patient who needs to carry out before examination, oral various bowel cleaning agents, accurately record the time of patient oral purgative, and the reference is provided for anaesthetic risk assessment, accurately record the stool frequency of patient, and the quality of bowel preparation is evaluated, and the water sample of patient is compared to the standardization, and the operation is convenient.

The application discloses a kind of spleen dampness and laxative of medicine food homologous composition and preparation method thereof, and the application relates to the technical field of traditional Chinese medicine, the medicine food homologous composition is made of the following functional components: intestinal laxative component, probiotic component, spleen dampness and Yang warming and Qi supplementing component and blood replenishing and intestinal component, the intestinal laxative component is psyllium husk powder, the probiotic component is Radix Sophorae Tonkinensis, by soluble dietary fiber water absorption softening stool, probiotic regulation intestinal microecology, sugar beet root powder nourishing blood and moistening intestine, realize the comprehensive effect of "moistening but not cold, unobstructed but not laxative, supplementing but not stagnating", avoid the drawbacks that traditional bitter cold purgative damages spleen qi and aggravates constipation, and clinical verification can significantly increase autonomous defecation frequency, improve sticky and unsmooth stool and abdominal distension and other accompanying symptoms, and all raw materials are medicine food homologous substances, long-term use is safe, suitable for spleen deficiency and dampness type constipation and unsmooth stool population.

The invention relates to an intestine-moistening and bowel-relaxing composition capable of being used for preparing popping beads. The intestine-moistening and bowel-relaxing composition comprises one or a combination of more of psyllium seed, fig pulp, apple pulp, lemon juice, polyxylose, stachyose, jujube and astragalus membranaceus. The popping bead is prepared on the basis of food and medicine substances, and the popping bead is relatively simple in preparation process, relatively low in cost and suitable for large-scale production. The obtained popping beads are good in taste and wide in application, can be directly eaten, and can also be used as an auxiliary material to be added into various beverages popular in the market, such as milk tea, coconut juice, fruit tea and the like. In the function, the popping bead can increase and regulate the water content of excrement, promote intestinal tract movement, shorten the defecation time and effectively relieve constipation; and moreover, the popping bead does not contain powerful laxative, so that the popping bead is prevented from injuring the body, and is high in safety and suitable for long-term consumption of consumers.

The present invention describes a dietary supplement consisting of a first plurality of daily doses of a laxative composition (A) comprising Psyllium, MgO, and fennel dry extract.; and a second plurality of daily doses of a probiotic and prebiotic composition (B) comprising B. lactis, B. longum, and FOS. Subject-matter of the present invention is therefore also a food supplement as described above for use in the treatment of constipation, linked to the intake of drugs, constipation-predominant IBS, chronic constipation, or acute constipation, characterized in that the plurality of doses of composition (B) are taken sequentially to a number of doses of composition (A).

A method, model, and system for screening predictive factors of perioperative hypoglycemia during gastrointestinal endoscopy, relating to the field of medical technology, is disclosed. This method employs univariate analysis and multivariate logistic regression to screen seven statistically significant factors from various factors influencing perioperative hypoglycemia during gastrointestinal endoscopy, defining these as hypoglycemia predictive factors. These seven factors are: blood urea nitrogen, preoperative blood glucose, glycated hemoglobin, nutritional status, laxative use, diagnostic category, and diastolic blood pressure. The outcome event of the predictive model is set as whether the patient experiences perioperative hypoglycemia, and the input factors are the seven screened hypoglycemia predictive factors. The predictive system includes a data input module and a hypoglycemia prediction module, with the hypoglycemia prediction module containing a built-in hypoglycemia risk prediction model. The model and system provided by this invention can provide hypoglycemia risk assessment for perioperative patients, assisting clinicians in decision-making.

1. Name of the product in this design: Laxative Cup. 2. Purpose of this design: For holding and dispensing laxatives. 3. The key design features of this product are the combination of shape and pattern. 4. The image or photograph that best illustrates the design's key points: a 3D model.

This invention relates to a device and medium for assessing the risk of inadequate bowel preparation in patients taking oral magnesium sulfate. The device includes: a data acquisition module for acquiring various risk assessment indicators for patients taking oral magnesium sulfate, including indicators of stroke or dementia, inflammatory bowel disease, heart or kidney failure, colonic stenosis, medication history, dietary type, taste of laxatives, preferred laxatives, history of failed bowel preparation, adverse events, complete administration, and yellow watery stools; and a bowel preparation inadequate risk assessment module for assigning values ​​to the acquired risk assessment indicators to assess the risk of inadequate bowel preparation. Compared with existing technologies, this invention has the advantages of comprehensively and accurately assessing the risk of inadequate bowel preparation, and has good discrimination and calibration.